Stralem & Co’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | $3.95M | Sell |
35,225
-410
| -1% | -$46K | 2.52% | 26 |
|
|
2020
Q1 | $3.2M | Buy |
35,635
+1,200
| +3% | +$108K | 2.38% | 27 |
|
|
2019
Q4 | $3.72M | Sell |
34,435
-1,460
| -4% | -$158K | 2.08% | 35 |
|
|
2019
Q3 | $3.52M | Sell |
35,895
-260
| -0.7% | -$25.5K | 2.03% | 32 |
|
|
2019
Q2 | $4.74M | Sell |
36,155
-7,810
| -18% | -$1.02M | 2.58% | 27 |
|
|
2019
Q1 | $5.94M | Sell |
43,965
-3,655
| -8% | -$494K | 2.72% | 26 |
|
|
2018
Q4 | $4.64M | Sell |
47,620
-20,015
| -30% | -$1.95M | 2.21% | 29 |
|
|
2018
Q3 | $9.4M | Sell |
67,635
-13,900
| -17% | -$1.93M | 2.79% | 23 |
|
|
2018
Q2 | $10.1M | Sell |
81,535
-35,550
| -30% | -$4.41M | 2.99% | 18 |
|
|
2018
Q1 | $13.1M | Buy |
+117,085
| New | +$13.1M | 2.59% | 26 |
|